Fen Xu

2.1k total citations · 1 hit paper
76 papers, 1.4k citations indexed

About

Fen Xu is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Fen Xu has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Fen Xu's work include Liver Disease Diagnosis and Treatment (16 papers), Pancreatic function and diabetes (14 papers) and Adipose Tissue and Metabolism (13 papers). Fen Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Pancreatic function and diabetes (14 papers) and Adipose Tissue and Metabolism (13 papers). Fen Xu collaborates with scholars based in China, United States and Sweden. Fen Xu's co-authors include Jianping Weng, Hua Liang, Mengyin Cai, Jianping Ye, Huanyi Cao, Zonglan Chen, Zhan‐Guo Gao, Jun Yin, Xiaobin Zheng and Chantal A. Rivera and has published in prestigious journals such as PLoS ONE, Hepatology and Diabetes.

In The Last Decade

Fen Xu

74 papers receiving 1.4k citations

Hit Papers

SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p ... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
    2023 76 citations Zhiping Wan, Mengyin Cai et al. profile →

Peers

Fen Xu
Sung‐E Choi South Korea
Bryce J. van Denderen Australia
Sabina Paglialunga Canada
Yachun Han China
Sarah R. Sikkema Canada
Guijun Qin China
Mengyin Cai China
Francesca Saba Italy
Stephan Winnik Switzerland
Sophie Hébrard France
Sung‐E Choi South Korea
Fen Xu
Citations per year, relative to Fen Xu Fen Xu (= 1×) peers Sung‐E Choi

Countries citing papers authored by Fen Xu

Since Specialization
Citations

This map shows the geographic impact of Fen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Xu more than expected).

Fields of papers citing papers by Fen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Xu. The network helps show where Fen Xu may publish in the future.

Co-authorship network of co-authors of Fen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fen Xu. A scholar is included among the top collaborators of Fen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fen Xu. Fen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cai, Xiang, et al.. (2025). SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2. Cellular and Molecular Life Sciences. 82(1). 159–159. 3 indexed citations
3.
Cheng, Huilin, Qi Liu, Fen Xu, et al.. (2024). Survivorship Experiences of Allogeneic Hematopoietic Stem Cell Transplantation Survivors. Cancer Nursing. 49(1). 70–79. 3 indexed citations
4.
Chen, Yunzhi, Xuemei Yan, Tian Wang, et al.. (2023). PNPLA3 148M/M Is More Susceptible to Palmitic Acid-Induced Endoplasmic Reticulum Stress-Associated Apoptosis in HepG2 Cells. International Journal of Endocrinology. 2023. 1–10. 1 indexed citations
5.
Cai, Xiang, Enming Zhang, Hua Liang, et al.. (2023). SIRT1-dependent deacetylation of Txnip H3K9ac is critical for exenatide-improved diabetic kidney disease. Biomedicine & Pharmacotherapy. 167. 115515–115515. 6 indexed citations
6.
Xu, Xiao, et al.. (2022). SIRT1 mediates nutritional regulation of SREBP-1c-driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation. Genes and Environment. 44(1). 18–18. 6 indexed citations
7.
Xu, Fen, Jiamin Zhang, Xiaoyan Zhou, & Hua Hao. (2022). Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway. Experimental Cell Research. 412(1). 113025–113025. 8 indexed citations
8.
Wan, Zhiping, et al.. (2022). M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model. iScience. 25(7). 104597–104597. 36 indexed citations
9.
Ansari, Abdur Rahman, et al.. (2021). Visfatin Regulates Inflammatory Mediators in Mouse Intestinal Mucosa Through Toll-Like Receptors Signaling Under Lipopolysaccharide Stress. Archivum Immunologiae et Therapiae Experimentalis. 69(1). 11–11. 12 indexed citations
10.
11.
Lin, Lan, Lin Wang, Fen Xu, et al.. (2020). BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway. International Immunopharmacology. 85. 106625–106625. 11 indexed citations
12.
13.
Xu, Fen, et al.. (2020). Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice. International Journal of Obesity. 44(4). 937–947. 29 indexed citations
14.
Chen, Yunzhi, Xuemei Yan, Xiao Xu, et al.. (2020). PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide. Endocrine. 70(3). 517–525. 10 indexed citations
15.
Lu, Sha, Fen Xu, Wensheng Hu, et al.. (2019). SCD1 methylation in subcutaneous adipose tissue associated with menopausal age. Climacteric. 22(4). 395–402. 3 indexed citations
16.
Yuan, Shuhua, Hongxia Liu, Yuan Ding, et al.. (2019). PNPLA3 I148M mediates the regulatory effect of NF‐kB on inflammation in PA‐treated HepG2 cells. Journal of Cellular and Molecular Medicine. 24(2). 1541–1552. 34 indexed citations
17.
18.
Chen, Zonglan, Weijuan Shao, Fen Xu, et al.. (2014). Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes. Cellular Signalling. 27(3). 587–597. 25 indexed citations
19.
Xu, Fen, Hongrong Deng, Yan Bi, et al.. (2013). PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1. PLoS ONE. 8(12). e84016–e84016. 10 indexed citations
20.
Sun, Weiping, Yan Bi, Hua Liang, et al.. (2010). Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats. Endocrine. 39(3). 235–241. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐E Choi Breakdown of academic impact, for papers by Bryce J. van Denderen Breakdown of academic impact, for papers by Sabina Paglialunga Breakdown of academic impact, for papers by Yachun Han Breakdown of academic impact, for papers by Sarah R. Sikkema Breakdown of academic impact, for papers by Guijun Qin Breakdown of academic impact, for papers by Mengyin Cai Breakdown of academic impact, for papers by Francesca Saba Breakdown of academic impact, for papers by Stephan Winnik Breakdown of academic impact, for papers by Sophie Hébrard
Rankless by CCL
2026